CTNM · Forms 3, 4, 5
Insider trades at Contineum Therapeutics, Inc.
1 insider sold $81K of Contineum Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Contineum Therapeutics, Inc. (CTNM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carmine N. Stengone | CEO and President | Option exercise | 2,500 | $1.01 | $3K | Form 4 | |
| Carmine N. Stengone | CEO and President | Sell (10b5-1 plan) | 2,500 | $16.46 | $41K | Form 4 | |
| Carmine N. Stengone | CEO and President | Option exercise | 2,500 | $1.01 | $3K | Form 4 | |
| Carmine N. Stengone | CEO and President | Sell (10b5-1 plan) | 2,500 | $16.01 | $40K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.